Fibromyalgia

Pain·MeSH: Fibromyalgia

15 drugs in development·13 companies·17 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
Cymbalta®	ELI LILLY & Co (LLY)
duloxetine	Inventiva S.A. (IVA)

Phase 3(5)

Drug	Company
AXS-14	Axsome Therapeutics, Inc. (AXSM)
Erenumab	UNITED THERAPEUTICS Corp (UTHR)
Erenumab-Aooe	UNITED THERAPEUTICS Corp (UTHR)
imc-1	Dogwood Therapeutics, Inc. (DWTX)
rozanolixizumab	GT Biopharma, Inc. (GTBP)

Phase 2(1)

Drug	Company
nyx-2925	Aptinyx Inc. (APTX)

Phase 1(1)

Drug	Company
sp-104	SCILEX HOLDING CO (SCLX)

Preclinical(4)

Drug	Company
feldetrex	PREMIER BIOMEDICAL INC (BIEI)
prtt-200	PROTECT PHARMACEUTICAL CORP (PRTT)
SP-26	Silo Pharma, Inc. (SILO)
stat-202	Statera Biopharma, Inc. (CBLI)

N/A(1)

Drug	Company
Crisugabalin	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 4(1)

Drug	Company
Pregabalin	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 15 drugs in development for Fibromyalgia across 13 companies.

There are 17 clinical trials targeting Fibromyalgia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.